We also found that protein levels of ABCB1, ABCC1 and ABCG2 are increased following doxorubicin and sorafenib treatment in the human HCC cells which was emphasized by GH treatment (Figures 4D–F). This evidence concerns the gene GH1 and hepatocellular carcinoma.